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Abstract
Background: multifactorial falls prevention programmes for older people have been proved to reduce falls. However,
evidence of their cost-effectiveness is mixed.
Design: economic evaluation alongside pragmatic randomised controlled trial.
Intervention: randomised trial of 364 people aged ≥70, living in the community, recruited via GP and identiﬁed as high
risk of falling. Both arms received a falls prevention information leaﬂet. The intervention arm were also offered a (day hos-
pital) multidisciplinary falls prevention programme, including physiotherapy, occupational therapy, nurse, medical review and
referral to other specialists.
Measurements: self-reported falls, as collected in 12 monthly diaries. Levels of health resource use associated with the
falls prevention programme, screening (both attributed to intervention arm only) and other health-care contacts were
monitored. Mean NHS costs and falls per person per year were estimated for both arms, along with the incremental cost-
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710effectiveness ratio (ICER) and cost effectiveness acceptability curve.
Results: in the base-case analysis, the mean falls programme cost was £349 per person. This, coupled with higher screening
and other health-care costs, resulted in a mean incremental cost of £578 for the intervention arm. The mean falls rate was
lower in the intervention arm (2.07 per person/year), compared with the control arm (2.24). The estimated ICER was
£3,320 per fall averted.
Conclusions: the estimated ICER was £3,320 per fall averted. Future research should focus on adherence to the interven-
tion and an assessment of impact on quality of life.
Keywords: cost-effectiveness, accidental falls, screening, comprehensive geriatric assessment, randomised controlled trial, elderly
Background
Falls are a common and serious problem for older people.
Multifactorial falls prevention programmes reduce the rate
of falls in people presenting to health services with a fall
[1]. However, the incidence of falls is sufﬁciently high and
the risk factors for falls are sufﬁciently well known, for it
to be feasible for falls programmes to be delivered to those
identiﬁed through screening. In an accompanying paper, we
tested such an approach in a multicentre randomised
controlled trial of people found through screening to be at
high risk of falls, which compared falls prevention delivered
in a day hospital with routine primary care. We found that
there was a non-statistically signiﬁcant reduction in the rate
of falls in the treatment arm. We argued that, when seen in
the context of other positive trials of falls prevention, our
trial showed that the provision of falls prevention to people
identiﬁed by screening was plausible and could well be clini-
cally effective. Evidence of the cost implications and cost-
effectiveness of such programmes is mixed [2]. The aim of
the present report is to provide a cost-effectiveness analysis
of this approach.
Methods
The economic evaluation was conducted alongside a prag-
matic randomised controlled trial (described elsewhere [3])
using cost and outcome data on individual patients.
Participants
Participants were community-dwelling older people (aged
70 and over), recruited from eight general practices in
the East Midlands, United Kingdom. Potentially eligible
participants were identiﬁed from a search of compu-
terised general practice records and were sent a written
invitation to participate in the study, which included a
falls risk questionnaire. The risk questionnaire was a self-
completed, modiﬁed version of the Falls Risk
Assessment Tool [4]. Potential participants were excluded
if they lived in a care home, were in receipt of end-of-life
care, had already attended a falls prevention programme,
were unwilling or unable to attend a falls prevention pro-
gramme or were unable to provide consent. Consenting
participants were allocated into the intervention or
control arm by research assistants, using an internet-based
randomisation service provided by the host institution’s
Clinical Trials Unit.
Intervention
Both arms received a falls prevention information leaﬂet
(‘Avoiding Slips, Trips and Broken Hips’ [5]). No further
intervention was offered to participants in the control arm,
who had access to all usual services, including referral to a
community or hospital-based falls prevention programme.
The intervention, undertaken at 3-day hospitals in Leicester
and Nottingham, was based on standard falls prevention
programme, similar to many falls prevention programmes
offered in similar settings throughout England and Wales
[2]. The programme was tailored to individual needs, incor-
porating a medical assessment, strength and balance train-
ing, a home hazards assessment and referral to other
specialists as necessary.
The primary outcome measure was the rate of self-
reported falls per year, collected over 12 months using
monthly diaries. Trial completion was deﬁned as 360 days
of follow-up from randomisation, time to institutionalisa-
tion or death. The trial started in February 2005 and the
last follow-up was completed in March 2008.
Measuring costs
In line with NICE guidance [6], the economic evaluation was
conducted from the viewpoint of the NHS and personal
social services (PSS), focusing on costs to the health service.
Costs of screening and recruitment to the trial were col-
lected using a top-down approach. One research secretary
(1.0 full time equivalent) and one research associate (0.5
full time equivalent) were employed exclusively for screen-
ing, which took place over 20 months. Printing, postage
and associated consumable costs were recorded. Research
costs, including telephone contact by the study team to
gain informed consent, were excluded. The total cost of
screening was calculated, along with cost per recruited par-
ticipant. In analysis, this was apportioned to participants in
the intervention arm only.
Levels of resource use associated with the falls preven-
tion programme were collected prospectively by day hospi-
tal staff, using a questionnaire to record the time spent by
Cost-effectiveness of preventing falls in older people
711clinicians, nurses and allied health professionals at each
attendance. Where these values were missing, we imputed
the average from all other respondents. Information on
referrals to other medical specialists and investigations
ordered (e.g. blood tests, cardiology investigations, bone
density scans) were also collected.
In line with guidance by the National Institute of Health
and Clinical Excellence (NICE) [6], we also collected
resource use information on items that we considered
could potentially relate to the intervention in question (this
assesses the possibility that provision of falls programme
averts costs that would otherwise have been incurred).
Consequently, participants were also asked to complete
questionnaires on health service resource use, including the
frequency and duration of visits with health-care pro-
fessionals, including primary care and details about the
speciﬁc type of service used (e.g. outpatient, emergency).
All self-reported health-care resource use was cross-
referenced to hospital and primary-care records and unit
costs ascribed, resulting in health service resource use data
over the full 12-month study period.
Unit costs are presented in pounds sterling from the
baseline year 2007–8 (PSSRU [7] and NHS Reference costs
[8]; Supplementary data are available in Age and Ageing
online). Neither health-care costs nor effects were dis-
counted, as the study period did not exceed 1 year.
Measuring outcomes
The primary outcome measure was rate of falls per year, so
the primary economic outcome was cost per fall averted.
Last observation carried forward method [9] was used to
impute missing monthly falls data.
Cost-effectiveness analysis
Cost-effectiveness of the falls prevention programme was
calculated by estimating the incremental cost per fall
averted [incremental cost-effectiveness ratio (ICER)], rela-
tive to usual care. T-tests were used to test for incremental
costs of the intervention compared with control, presenting
results as arithmetic means and standard deviations.
Uncertainty analysis
In order to estimate the level of uncertainty associated with
the decision as to which intervention was most cost-effective,
probabilistic methods were used to estimate the cost-
effectiveness acceptability curve (CEAC) for each intervention
arm. The CEAC depicts the probability that an intervention
is cost-effective at different levels of the cost-effectiveness
threshold (in this case, how the probability of cost-
effectiveness varies according to how much one is willing to
pay to avert one fall) [10]. Bootstrapping methods were
applied, which build up an empirical estimate of the sampling
distribution of the statistic in question by re-sampling from
the original data (in this case, 10,000 iterations).
Sensitivity analysis was used to assess the robustness of
conclusions to key assumptions [11]. To investigate the
effect of loss to follow-up, we examined cost-effectiveness
using complete case data only. A sensitivity analysis was
also performed eliminating extreme outlier values.
Results
Participants
There were 6,133 individuals aged over 70 registered with
the eight participating general practices, 844 of whom were
deemed unsuitable by their GP prior to invitation to the
trial. The remaining 5,289 were invited to participate and
2846 (54%) responded. Of those who responded, 1481
(52%) were deemed to be at high risk of falls and 364
(25%) agreed to participate in the trial. One hundred and
eighty-one were randomised into the control arm and 183
into the intervention arm. Thus, 364/6133 (6%) of all
people screened took up the offer of a trial of falls
prevention.
One participant in the intervention arm had attended a
falls prevention programme elsewhere in the year prior to
randomisation and was subsequently excluded. There were
9 withdrawals in the control arm and 10 in the intervention
arm, who provided no falls outcome data, so analyses were
based on 172 participants in each arm.
The baseline characteristics of the study population are
shown in Supplementary data available in Age and Ageing
online. The two study arms were well balanced with respect
to most characteristics, including age, previous falls history
and aggregated falls risk.
Falls rates
There were 260 self-reported falls in the intervention arm
and 417 falls among control participants. From 4140 avail-
able months (88.0% completion), 3644 falls diaries were
returned. After imputing missing falls data (this was necess-
ary for 91 participants: 47 intervention; 44 control), falls
rates (per person-year) were 2.07 in intervention arm and
2.85 among controls.
One participant in the control arm reported 107 non-
injurious falls over 11 months and was considered an
extreme outlier. Although intention-to-treat analysis favours
inclusion of all participants irrespective of exceptional cir-
cumstances experienced, this participant signiﬁcantly dis-
torted the level of falls averted between intervention and
control arms. For this reason, analysis was performed with
and without the outlier’s cost and falls data, but base-case
results were reported without this participant. Excluding
this participant reduced the falls rate in the control arm to
2.24 per person-year. We found no signiﬁcant differences
between the arms in terms of rate of falls or injuries
(Supplementary data are available in Age and Ageing online).
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Falls Prevention Programme costs
Screening costs were substantial, estimated at £59,900 or
£165 per participant eventually recruited into the study
(Supplementary data are available in Age and Ageing online).
In the analysis, this was apportioned to the intervention arm
only. The cost of the falls prevention programme varied
between subjects, reﬂecting the variability of attendance. The
mean number of sessions was 2.2 (range 0–21), the average
unit cost per session was £76.33 (range £3.35–469.36), and
the average overall falls prevention programme cost per par-
ticipant was £349.03 (Table 1). The level of missing data with
regard to reported staff time associated with each session
ranged from 21 to 24% in day hospital log sheets (data with
regard to the number of sessions was completed for all par-
ticipants). This was subsequently imputed using the mean
visit time for all other participants with complete data.
Health resource use
Health resource use questionnaires were returned by 320
participants (93%). By combining self-reported data and
data from medical records, the level of missing data for
health-care resources was reduced to an average of 0.5%
per variable (ranging between 0% for hospital outpatient
visits and A&E visits to 19.5% for self-reported duration
of GP visit). Table 2 shows the results of the cost analysis
for health-care resource use. Excluding intervention costs,
mean health-care costs in the intervention arm were
£1,722, compared with £1,659 for the control arm.
Participants randomised to the falls prevention programme
had fewer GP consultations recorded than those receiving
standard care; however, all other health resource use items
were slightly higher in the intervention arm. None of the
differences were statistically signiﬁcant. When the additional
cost of the falls screening and prevention programme was
added, average health care costs in the intervention arm
rose to £2,238.
The most inﬂuential cost in our study was due to over-
night hospital stays, with 34 participants in each arm receiv-
ing inpatient care during the follow-up period. Inpatient
admissions due to falls were particularly resource-intensive,
with a mean length of stay 29.4 days, compared with 10.9
days for non-falls-related admissions. Seven participants in
intervention arm were admitted to hospital with falls, in
....................................................................................
Table 1. Incremental costs of falls prevention programme
Cost item Number participants using
resource at least once (% of
172 intervention participants)
Resource use for the
intervention arm
Total cost
Medical consultation (full clinical history and physical examination and
referrals where appropriate)
118 (68.6%) 158 £21,962
Physiotherapy review (average 45 min) 125 (72.7%) 627 £17,870
Nurse review (average 28 min) 124 (72.1%) 535 £9,987
Occupational Therapy review (average 41 min) 70 (40.7%) 129 £3,614
Occupational therapy home visit 12 (7.0%) 13 £507
Falls-related diagnostic tests (including cardiac tests, blood tests, tilt test) 80 (46.5%) 170 £3,198
Other specialty consultation (e.g. dietician, continence clinic, orthotics) 18 (10.5%) 25 £1,374
Other investigations (e.g. DEXA scan, radiology) 10 (5.8%) 10 £1,104
Home modifications 11 (6.4%) 11 £417
Total cost of implementation £60,033
Average number of Falls sessions attended per participant (range) 2.2 (0–21)
Average cost per falls session attended (range) £76 (£3–469)
Average cost per participant over study period (range) £349 (£0–1,746)
....................................................................................
Table 2. Health service resource use, costs and mean difference in costs
Resource use item Resource use and mean cost per participant Mean incremental cost (95% CI)
Intervention arm (n=172) Control arm (n=171)
a
Resource use (units) Mean costs SD Resource use (units) Mean costs SD Incremental cost Lower Upper
GP consultations 1,043 £228 253 1,150 £247 205 −£19 −£554 £620
A&E visit 43 £38 80 33 £27 61 £11 −£189 £215
Outpatient first visit 65 £51 114 54 £42 100 £9 −£179 £313
Inpatient bed days 552 £1,374 4769 529 £1,317 4967 £57 −£8,158 £9,465
Practice nurse consultations 816 £31 78 748 £26 57 £5 −£101 £187
Falls prevention programme costs £349 316 —— £349 £0 £1,057
Screening costs £165 —— — — £165 ——
Total costs per participant £2,238 4957 £1,659 5100 £578 −£12,593 £17,264
Costs undiscounted (2007–8 UK £). SD, standard deviation.
aBase-case analysis excluded extreme outlier with 107 non-injurious falls.
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713comparison to six in the control arm (see Supplementary
data available in Age and Ageing online).
Cost-effectiveness
In the base-case using patient-level data, compared with
usual care, the falls prevention programme was both more
costly [mean incremental cost=£578 (95% conﬁdence
interval −£8188 to +£13,212)] and more effective [mean
incremental effect=0.17 falls averted per person-year (95%
conﬁdence interval −8.00 to +8.00)], with an incremental
cost per fall averted (ICER) of £3,320 (Table 3).
As part of the sensitivity analysis, when the participant
with 107 reported falls was included, the overall rate of falls
in the control arm was raised considerably, which may mis-
leadingly suggest increased cost-effectiveness of the falls
prevention programme, as a lower ICER value of £738 per
fall averted is generated, compared with usual care. The
second sensitivity analysis, including only participants who
completed all 12 monthly falls diaries, resulted in ICER
result much closer to the base case (£3,118 per fall averted,
compared with £3,320).
Decision uncertainty
ACEA CisplottedinFigure1. ACEAC provides information
about the probability that an intervention is cost-effective,
given a decision-maker’s willingness to pay for each additional
health improvement (e.g. per fall averted). Compared with
usual care, the probability that the intervention was cost-
effective was always less than 40%, even if decision-makers
were willing to pay more than £5,000 per fall averted.
Discussion
This study tested a ‘screen and intervene’ approach to prevent
future falls for at risk community-dwelling older people. The
incremental falls averted per person-year was 0.17 (from 2.24
to 2.07 standardised falls rate). The falls prevention pro-
gramme was more costly than usual care, yet neither incre-
mental costs nor differences in effectiveness were signiﬁcant.
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Figure 1. CEAC: cost per fall averted.
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714The incremental cost per fall averted was £3,320. The
decision to implement a falls prevention programme for a
screened population would thus depend upon whether the
health-care funder would put the value of averting acciden-
tal falls at a threshold value greater than £3,320 per fall
averted.
Three limitations of the availability of economic data in
this study warrant discussion. First, contrary to the hypoth-
esis that costs of implementing an intervention may be offset
by a decrease in the use of other health services, we found
health-care resource use was slightly higher in the interven-
tion arm (Table 2). Baseline costs were not measured and
hence it is unclear if previous falls had resulted in high levels
of health resource use or whether there were signiﬁcant base-
line cost differences between study arms. Costs incurred after
randomisation constitute the cost outcome of interest in the
trial. However, costs incurred prior to randomisation are a
potential predictor of costs after randomisation and may
explain variability in this cost.
Secondly, our economic evaluation took the perspective
of the NHS, as opposed to social care or a patient perspec-
tive. Although data on PSS costs were collected, this was by
self-report only and the proportion of missing data was
high. Similarly, we did not include the cost of lost pro-
ductivity in our comparative analysis. Further investigation
of patient costs and societal factors may be justiﬁed.
Finally, cost-effectiveness analysis was adopted, measur-
ing cost per fall averted. It is important to note that the
results presented here will only be relevant to decisions
concerning how best to allocate a speciﬁc ‘falls-prevention’
budget. To enable comparison of different health-care inter-
ventions on a common scale, cost-utility analyses would
need to be conducted. Cost-utility analysis would allow
greater comparative value with competing health-care
packages, including those unrelated to falls. In addition, our
analysis was limited to a 12-month follow-up period, which
may have led to an underestimation of long-term costs and
effects associated with the intervention.
It should be noted that the falls rates reported in this
study are different from those reported in the clinical
paper, as the economic study used imputation to generate a
complete data set for falls and allow the maximum use of
the economic data.
As detailed in a recent systematic review [2],studies have
previously estimated the cost-effectiveness of multifactorial
falls prevention strategies, but none in a UK population.
The absence of strong conclusions of cost-effectiveness in
this study mirrors recent research on falls prevention in the
Netherlands [12], which found the intervention to be more
expensive, but with additional health beneﬁts—neither of
which were statistically signiﬁcant. We report higher costs
and lower falls rates compared with usual care, but neither
were greater than could have occurred by chance
Overall, we conclude there is a lack of evidence to
suggest targeted screening in primary care and multifactorial
falls prevention programmes in a day hospital setting is cost-
effective. Although a reduction in the rate of falls occurred,
costs were higher. More research into factors underlying
uptake to screening, adherence to such programmes,
health-related outcomes and personal and social cost conse-
quences of falls and falls prevention is warranted.
Key point
• A day hospital-based falls prevention programme
delivered to a screened population of older people at
risk of future falls was associated with fewer falls, but
was more costly than usual care.
Contributors
Dr Rob Morris, Nottingham University Hospitals NHS
Trust, Dr Pradeep Kumar, Royal Lancaster Inﬁrmary,
Dr Jane Youde, Derbyshire Hospitals, Ms Rachel Taylor,
Nottingham University Hospitals NHS Trust and Dr Judi
Edmans, School of Community Health Sciences, University
of Nottingham Medical School.
T.M. conceived the idea and coordinated the initial suc-
cessful pump priming funding application. T.S./S.P.C.
helped with trial design, managed the trial and revised the
paper. L.I./G.B. carried out the analysis, prepared the
paper and edited comments. D.K., C.C., R.H.H., J.R.F.G.,
A.D. and T.M. all contributed to the trial design, trial deliv-
ery, interpretation of analyses and revision of the paper. All
authors had full access to all of the data (including statistical
reports and tables) in the trial and can take responsibility
for the integrity of the data and the accuracy of the data
analysis. S.P.C. acts as guarantor.
Supplementary data
Supplementary data mentioned in the text is available to
subscribers in Age and Ageing online.
Funding
Funding for the trial was obtained from Nottinghamshire,
Derbyshire and Lincolnshire research alliance, Research into
Ageing, the British Geriatrics Society and Nottingham
University Hospitals NHS trust. The funders had no role in
the trial design, analysis or preparation of the publication.
The main trial sponsor was the University of Nottingham,
with Nottingham University Hospitals NHS trust and
Derbyshire hospitals NHS trust acting as co-sponsors.
Ethical approval
Ethical approval for the trial was obtained from
Nottingham 2 ethics committee (reference 04/Q2404/93).
All trial participants gave fully informed, written consent.
Cost-effectiveness of preventing falls in older people
715Trial registration
The trial was registered with Current Controlled Trials
Ltd (reference number ISRCTN46584556) and the trial
protocol published 27.2.6 (http://www.trialsjournal.com/
content/7/1/5).
References
1. Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE,
Cumming RG, Rowe BH. Interventions for preventing falls in
elderly people. Cochrane Database Syst Rev 2001: CD000340.
2. Lamb SE. Scoping Exercise on Fallers’ Clinics, 2007.
3. Masud T, Coupland C, Drummond A et al Multifactorial day
hospital intervention to reduce falls in high risk older people
in primary care: a multi-centre randomised controlled trial
[ISRCTN46584556]. Trials 2006; 7: 5.
4. Conroy S. Preventing Falls in Older People. University of
Nottingham, 2009.
5. Anon. Avoiding Slips, Trips and Broken Hips. In: Department
of Trade and Industry, ed. HMSO, 2001.
6. NICE. Guide to the Methods of Technology Appraisal.
London: National Institute of Health and Clinical Excellence,
2008.
7. Curtis L, Netten A. University of Kent at Canterbury.
Personal Social Services Research U. Unit costs of health and
social care 2008. Canterbury: University of Kent at
Canterbury, Personal Social Services Research Unit, 2008.
8. Executive NHS. The New NHS 2008 Reference Costs.
Department of Health, 2008.
9. Little RJA, Rubin DB. Statistical analysis with missing data.
2nd edition. Hoboken, NJ (Chichester): Wiley, 2002.
10. Fenwick E, Claxton K, Sculpher M. Representing uncertainty:
the role of cost-effectiveness acceptability curves. Health
Econ 2001; 10: 779–87.
11. Drummond MF. Methods for the economic evaluation of
health care programmes, 3rd edition. Oxford: Oxford
University Press, 2005.
12. Hendriks MR, Evers SM, Bleijlevens MH, van Haastregt JC,
Crebolder HF, van Eijk JT. Cost-effectiveness of a multidisciplin-
ary fall prevention program in community-dwelling elderly
people: a randomized controlled trial (ISRCTN 64716113). Int J
Technol Assess Health Care 2008; 24: 193–202.
Received 17 December 2009; accepted in revised form
20 July 2010
Age and Ageing 2010; 39: 716–722
doi: 10.1093/ageing/afq097
Published electronically 4 September 2010
© The Author 2010. Published by Oxford University Press on behalf of the British Geriatrics Society.
All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The oldest old and GP end-of-life care in the
Dutch community: a nationwide study
EBUN ABARSHI
1,2,M ICHAEL A. ECHTELD
1,2,L IEVE VAN DEN BLOCK
3,G É DONKER
4,L UC DELIENS
1,2,3,
BREGJE ONWUTEAKA-PHILIPSEN
1,2
1Department of Public and Occupational Health, The EMGO Institute for Health and Care Research, VU University Medical
Center, Amsterdam, The Netherlands
2Palliative Care Expertise Centre, VU University Medical Center, Amsterdam, The Netherlands
3End-of-Life Care Research Group, Department of General Practice, Vrije Universiteit Brussel, Brussels, Belgium
4Netherlands Institute for Health Services Research, Utrecht, The Netherlands
Address correspondence to: Ebun Abarshi. Tel: (+31) 20 4449816; Fax: (+31) 20 4448387; Email: ebun.abarshi@vumc.nl,
ebunabarshi@yahoo.com
Abstract
Background: Provision of adequate care for the oldest old is increasingly crucial, given the current ageing trends. This
study explores differences in end-of-life care of the oldest (≥85 years) versus the younger (65–84 years) old; testing the
hypothesis that age could be an independent correlate of receiving specialised palliative care services (SPCS), having pallia-
tive-centred treatment and dying in a preferred place.
Methods: general practitioners (GPs) participating in the nation-wide representative network in the Netherlands were asked
to ﬁll in patient, illness and care characteristics of all registered patients ≥65 years, who died non-suddenly in their practices
between 2005 and2008, using standardised forms. Associations with the palliative care variables were tested using multiple
logistic regression.
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